Airtime: Mon. Feb. 22 2010 | ET
Dr. Steven Nissen, of the Cleveland Clinic, authored a controversial study identifying heart risks in GlaxoSmithKline’s Avandia diabetes drug. He talks to CNBC’s Mike Huckman.
Study Identifies Heart Risks in Glaxo's Avandia
![](https://www.50parkinvestments.com/wp-content/uploads/2018/04/50-park-investments-logo.png)
22
Feb